Administration of ticarcillin, a new antipseudomonal antibiotic, in patients undergoing dialysis

Ticarcillin was administered to three groups of patients in chronic renal failure; three were undergoing chronic hemodialysis, two were undergoing peritoneal dialysis, and three received the drug after hemodialysis. The serum half-lives were measured. A dosage regime for patients undergoing dialysis is suggested.